These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23796286)
1. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management. Cao Q; Postmus D; Hillege HL; Buskens E Value Health; 2013 Jun; 16(4):529-35. PubMed ID: 23796286 [TBL] [Abstract][Full Text] [Related]
2. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941 [TBL] [Abstract][Full Text] [Related]
3. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Ijzerman MJ; Steuten LM Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163 [TBL] [Abstract][Full Text] [Related]
4. Early technology assessment of new medical devices. Pietzsch JB; Paté-Cornell ME Int J Technol Assess Health Care; 2008; 24(1):36-44. PubMed ID: 18218167 [TBL] [Abstract][Full Text] [Related]
5. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model. Tappenden P; Chilcott J; Brennan A; Squires H; Glynne-Jones R; Tappenden J Value Health; 2013 Jun; 16(4):542-53. PubMed ID: 23796288 [TBL] [Abstract][Full Text] [Related]
6. Approaches for economic evaluations of health care technologies. Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571 [TBL] [Abstract][Full Text] [Related]
7. HEADROOM APPROACH TO DEVICE DEVELOPMENT: CURRENT AND FUTURE DIRECTIONS. Girling A; Lilford R; Cole A; Young T Int J Technol Assess Health Care; 2015 Jan; 31(5):331-8. PubMed ID: 26694550 [TBL] [Abstract][Full Text] [Related]
8. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. Kang HY; Ko SK; Liew D Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032 [TBL] [Abstract][Full Text] [Related]
9. A method for the early health technology assessment of novel biomarker measurement in primary prevention programs. Postmus D; de Graaf G; Hillege HL; Steyerberg EW; Buskens E Stat Med; 2012 Oct; 31(23):2733-44. PubMed ID: 22806952 [TBL] [Abstract][Full Text] [Related]
10. Spanish recommendations on economic evaluation of health technologies. López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159 [TBL] [Abstract][Full Text] [Related]
11. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572 [TBL] [Abstract][Full Text] [Related]
12. Experiences of new product development in the medical device industry. Dixon D; Brown A; Meenan BJ; Eatock J Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659 [TBL] [Abstract][Full Text] [Related]
13. Alternative approaches for assessing the socioeconomic benefits of medical devices: a systematic review. Wilkinson G; Drummond M Expert Rev Med Devices; 2015; 12(5):629-48. PubMed ID: 26305841 [TBL] [Abstract][Full Text] [Related]
14. Early decision-analytic modeling - a case study on vascular closure devices. Brandes A; Sinner MF; Kääb S; Rogowski WH BMC Health Serv Res; 2015 Oct; 15():486. PubMed ID: 26507131 [TBL] [Abstract][Full Text] [Related]
15. How to value technological innovation: a proposal for determining relative clinical value. Ladabaum U; Brill JV; Sonnenberg A; Shaheen NJ; Inadomi J; Wilcox CM; Park WG; Hur C; Pasricha PJ Gastroenterology; 2013 Jan; 144(1):5-8. PubMed ID: 23153872 [No Abstract] [Full Text] [Related]
16. Subject variation more than values clarification explains the reliability of willingness to pay estimates. Shiell A; McIntosh K Health Econ; 2008 Feb; 17(2):287-92. PubMed ID: 17619235 [TBL] [Abstract][Full Text] [Related]
17. Early-stage valuation of medical devices: the role of developmental uncertainty. Girling A; Young T; Brown C; Lilford R Value Health; 2010 Aug; 13(5):585-91. PubMed ID: 20412542 [TBL] [Abstract][Full Text] [Related]
18. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872 [TBL] [Abstract][Full Text] [Related]
19. Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia. Fauli S; Thue G Eur J Health Econ; 2008 Aug; 9(3):221-8. PubMed ID: 17570004 [TBL] [Abstract][Full Text] [Related]
20. Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review. Hartz S; John J Int J Technol Assess Health Care; 2008; 24(4):465-72. PubMed ID: 18828942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]